Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2990818 | Journal of Vascular Surgery | 2011 | 9 Pages |
Abstract
The operative indication for a TEVAR procedure was not found to be a predictor of poor patient outcome. Surgical complexity, specifically the need for brachiocephalic aortic debranching and aortoiliac conduit, was shown to influence the occurrence of SAEs in a multivariate model. Comparative data, such as these, illustrate real-world outcomes of patients undergoing TEVAR outside of the original FDA-approved indications. This information is of paramount importance to various stakeholders, including third-party payers, the device industry, regulatory agencies, surgeons, and their patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Bryan A. MD, Christopher A. MD, Frank M. DO, William M. MD, Charles S. MD, Michael C. MD, RVT,